Food & Water Europe Tells Why FDA Should Ban Transgenic Salmon

A new report from Food & Water Europe says the inferior nutritional value and high costs of producing genetically-engineered  salmon will mean that, contrary to arguments offered by the GE fish’s developer, it will not alleviate global food shortages. The transgenic salmon developed by U.S. firm AquaBounty is being considered by the U.S. FDA for approval as a human food. The report says GE salmon can require large amounts of food, display deformities and likely have higher oxygen demands, making them expensive to produce, and therefore impractical for growers and consumers. According to F&EW, GE salmon have 35 percent fewer omega-3 fatty acids. The report also says that escapees from the GE salmon population could alter the genetic integrity of wild Atlantic salmon and Scottish farmed salmon.